Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Nu Holdings
NU
|
$652M |
| 2 |
Symbotic
SYM
|
$427M |
| 3 |
Coupang
CPNG
|
$411M |
| 4 |
Meta Platforms (Facebook)
META
|
$363M |
| 5 |
Mobileye
MBLY
|
$243M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$3.14B |
| 2 |
Spotify
SPOT
|
$579M |
| 3 |
Broadridge
BR
|
$577M |
| 4 |
Mercado Libre
MELI
|
$524M |
| 5 |
Charles Schwab
SCHW
|
$501M |
Sector Composition
| 1 | Technology | 28.97% |
| 2 | Consumer Discretionary | 27.33% |
| 3 | Communication Services | 14.17% |
| 4 | Healthcare | 14.03% |
| 5 | Financials | 5.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
251
DELISTED
Sage Therapeutics
SAGE
| $1.51M | ﹤0.01% |
80,816
-3,949
| -5% | -$74K |
|
252
Lyell Immunopharma
LYEL
$225M
| $1.46M | ﹤0.01% |
32,808
-1,736
| -5% | -$77.4K |
|
|
GOOS
253
Canada Goose Holdings
GOOS
$1.27B
| $1.44M | ﹤0.01% |
119,221
| – | – |
|
|
AKLI
254
DELISTED
Akili, Inc. Common Stock
AKLI
| $1.35M | ﹤0.01% |
4,665,795
| – | – |
|
|
NYAX
255
Nayax
NYAX
$1.83B
| $1.3M | ﹤0.01% |
+49,470
| New | +$1.3M |
|
256
Spire Global
SPIR
$272M
| $1.3M | ﹤0.01% |
108,255
| – | – |
|
257
Southern Company
SO
$101B
| $1.26M | ﹤0.01% |
+17,500
| New | +$1.26M |
|
258
Equity Residential
EQR
$25B
| $1.1M | ﹤0.01% |
17,469
+4,269
| +32% | +$269K |
|
259
BCE
BCE
$22.8B
| $1.06M | ﹤0.01% |
31,257
| – | – |
|
260
Consolidated Edison
ED
$35.3B
| $1.06M | ﹤0.01% |
11,628
| – | – |
|
261
Novanta
NOVT
$4.15B
| $952K | ﹤0.01% |
5,445
-2,320
| -30% | -$405K |
|
262
Varonis Systems
VRNS
$6.24B
| $905K | ﹤0.01% |
19,176
-7,338
| -28% | -$346K |
|
263
Digital Realty Trust
DLR
$55.5B
| $880K | ﹤0.01% |
6,109
+1,313
| +27% | +$189K |
|
264
Healthpeak Properties
DOC
$12.5B
| $658K | ﹤0.01% |
+35,086
| New | +$658K |
|
|
265
Charles Schwab
SCHW
$177B
| $656K | ﹤0.01% |
9,074
-6,927,621
| -100% | -$501M |
|
266
CarGurus
CARG
$3.59B
| $536K | ﹤0.01% |
23,209
-8,049
| -26% | -$186K |
|
267
Xencor
XNCR
$597M
| $504K | ﹤0.01% |
22,786
-8,219
| -27% | -$182K |
|
268
Healthcare Realty
HR
$6.15B
| $490K | ﹤0.01% |
34,659
+3,965
| +13% | +$56.1K |
|
|
MTLS
269
Materialise
MTLS
$294M
| $439K | ﹤0.01% |
83,119
| – | – |
|
270
Bandwidth Inc
BAND
$472M
| $395K | ﹤0.01% |
21,623
-8,067
| -27% | -$147K |
|
271
Allbirds
BIRD
$53M
| $370K | ﹤0.01% |
26,625
| – | – |
|
272
Calix
CALX
$3.99B
| $315K | ﹤0.01% |
9,485
-3,411
| -26% | -$113K |
|
273
Howard Hughes
HHH
$4.62B
| $233K | ﹤0.01% |
3,373
-2,588,178
| -100% | -$179M |
|
|
RDFN
274
DELISTED
Redfin
RDFN
| $106K | ﹤0.01% |
15,931
-5,861
| -27% | -$39K |
|
275
Hubbell
HUBB
$23.2B
| $78K | ﹤0.01% |
188
+87
| +86% | +$36.1K |
|